Showing results (471-480 of 548) with videos related to

Sort By:
Pageof 55
Diabetes & Metabolism|May 23, 2018
Platelet function following induced hypoglycaemia in type 2 diabetesH Kahal, A Aburima, B Spurgeon, et al.
The Journal of Experimental Medicine|March 1, 1996
The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogensB C Cole, K L Knudtson, A Oliphant, et al.
Nutrients|January 20, 2019
A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary SyndromeZeeshan Javed, Maria Papageorgiou, Harshal Deshmukh, et al.
Clinical Endocrinology|September 5, 2019
Alterations in long noncoding RNAs in women with and without polycystic ovarian syndromeAlexandra E Butler, Shahina Hayat, Soha R Dargham, et al.
Clinical Endocrinology|March 14, 2019
Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled studyZeeshan Javed, Maria Papageorgiou, Harshal Deshmukh, et al.
Scientific Reports|November 10, 2019
Expression of microRNA in follicular fluid in women with and without PCOSAlexandra E Butler, Vimal Ramachandran, Shahina Hayat, et al.
Diabetes Care|December 19, 2015
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical TrialMelanie J Davies, Stephen C Bain, Stephen L Atkin, et al.
International Journal of Molecular Sciences|October 29, 2025
Differential Expression of Complement Pathway Components in Unexplained Infertility Versus Male Factor Infertility: Insights from an Exploratory Pilot StudyEdwina Brennan, Marya K E A Radhi, Zainab A A H Husain, et al.
Diabetes Care|January 24, 2013
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetesLuigi Meneghini, Stephen L Atkin, Stephen C L Gough, et al.
Annals of Internal Medicine|May 5, 2015
The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort studyPierluigi Costanzo, John G F Cleland, Pierpaolo Pellicori, et al.
Pageof 55